| 2922.39.17 | 00 | 1-Aminoanthraquinone | kg | Free | | 15.4￠/kg + 50% |
| 2922.41.00 | 10 | Meeting requirements of Food Chemical Codex, Codex Alimentarius or United States Pharmacopeia | kg | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 53% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-￠/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.39.15 | 00 | Quinuclidin-3-ol | kg | 5.8% | Free (A+,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.08 | 00 | 4,7-Dichloroquinoline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 52% |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4￠/kg + 52% |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.99.02 | 00 | 2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]- propionic acid, ethyl ester; and O,O-Dimethyl-S-[(4-oxo-1,2,3-benzotri- azin-3-(4H)-yl)methyl]phosphorodithioate | kg | Free | | 15.4￠/kg + 64.5% |
| 2933.99.08 | 00 | Acetoacetyl-5-aminobenzimidazolone; 3-(2H-Benzotriazol-2-yl)-5-(tert-butyl)-4- hydroxybenzene propanoic acid, C7-C9 branched or linear alkyl esters; 2-(2H-Benzotriazol-2-yl)-6-dodecyl-4- methyl phenol, in liquid form, branched and linear; and 1,3,3-Trimethyl-2-methyleneindoline | kg | Free | | 15.4￠/kg + 52% |
| 2933.99.12 | 00 | 6-Bromo-5-methyl-1H-imidazo[4,5-b]- pyridine; 2-sec-Butyl-4-tert-butyl-6-(benzotriazol-2- yl)phenol; 2-tert-Butyl-4-methyl-6-(5-chlorobenzotri- azol-2-yl)phenol; 2,4-Di-tert-butyl-6-(benzotriazol-2-yl)phenol; 2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2- yl)phenol; 2,3-Dichloro-6-quinoxalinecarbonyl chloride; 1-Hydroxy-2-carbazolecarboxylic acid; 2-Hydroxy-3-carbazolecarboxylic acid; 2-Hydroxy-3-carbazolecarboxylic acid, sodium salt; Iminodibenzyl(10,11-dihydro-5H-dibenz- [b,f]azepine); Indoline; 3-Methylbenzo[f]quinoline; 2-Methylindoline; 2-Methylmercaptobenzimidazole; 1-Methyl-2-phenylindole; 1-Methylpyrazine; 2,4-Methylpyrazolic acid; 2-Phenylbenzimidazole; 2-Phenylindole; Tetramethylpyrazine; 2,3,5-Triphenyltetrazolium chloride; dl-Tryptophan; and Vinylcarbazole, monomer | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.99.58 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents: | | | | |
| 2934.30.23 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2939.20.00 | 10 | Quinine and its salts | g | | | |
| 3004.40.00 | 30 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | | | |
| 3004.90.91 | 35 | Antidepressants, tranquilizers, and other psychotherapeutic agents | kg | | | |
| 3103.10.00 | 10 | Normal and enriched superphosphates, less than 40 percent available phosphorus pentoxide (P2O5) equivalent | t | | | |
| 3103.10.00 | 20 | Concentrated superphosphates, 40 percent or more available phosphorus pentoxide (P2O5) equivalent | t | | | |
